Vance Street Capital LLC has hired John LeRosen as vice president. Previously, LeRosen worked at Avalon Laboratories where he was chief financial officer.
LOS ANGELES – August 10, 2015 – Vance Street Capital LLC, a Los Angeles-based private equity firm, announced today that John LeRosen has joined the firm as Vice President. LeRosen will be primarily responsible for sourcing and executing transactions as well as working with portfolio company management teams.
“We’ve known John for many years and are very pleased that he is joining Vance Street,” said Richard Crowell, Managing Partner “John brings a wealth of operational knowledge and deal experience that will prove invaluable as Vance Street continues to grow its portfolio. In particular, John’s insights on the precision medical component industry, both as a former CFO and an investor in precision medical components companies, will greatly benefit our existing and future portfolio companies.”
Prior to joining Vance Street Capital, LeRosen served as Chief Financial Officer of Avalon Laboratories, a medical device manufacturer of specialty medical tubing that was sold to Nordson in 2014. Before that, LeRosen was on the American Capital team that led the investment in Avalon Laboratories. During his eight years at American Capital he focused on investing and providing financial due diligence support across dozens of companies in medical components and devices, specialty manufacturing, life sciences and industrial technology sectors. He began his career at KPMG performing financial audits as a certified public accountant. LeRosen earned a Bachelor of Business Administration with an emphasis in Accounting from James Madison University.
“I am thrilled to be joining Vance Street Capital,” LeRosen said. “Vance Street provides management teams with a level of support and industry insight rarely found in the middle market. I look forward to working closely with the firm’s talented team of investors and business operators.”
About Vance Street Capital
Vance Street Capital is a Los Angeles-based private equity firm that makes control investments in companies with enterprise values up to $200 million. Preferred industries include industrial manufacturing, aerospace, defense, and precision medical components and devices. For over two decades, Vance Street’s partners have worked with management, family owners and other co-investors to accelerate revenue growth, improve operations and acquire strategic assets for the companies in their investment portfolio. For more information please visit: www.vancestreetcapital.com